RU2246483C2 - Эфиры 5-аминолевулиновой кислоты как фоточувствительные агенты в фотохимиотерапии - Google Patents

Эфиры 5-аминолевулиновой кислоты как фоточувствительные агенты в фотохимиотерапии Download PDF

Info

Publication number
RU2246483C2
RU2246483C2 RU2003105460/04A RU2003105460A RU2246483C2 RU 2246483 C2 RU2246483 C2 RU 2246483C2 RU 2003105460/04 A RU2003105460/04 A RU 2003105460/04A RU 2003105460 A RU2003105460 A RU 2003105460A RU 2246483 C2 RU2246483 C2 RU 2246483C2
Authority
RU
Russia
Prior art keywords
ala
compound
substituted
group
photochemotherapy
Prior art date
Application number
RU2003105460/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2003105460A (ru
Inventor
Йо КЛАВЕНЕСС (NO)
Йо Клавенесс
Нильс Олаф НИЛЬСЕН (NO)
Нильс Олаф НИЛЬСЕН
Йон Эрик БРЕНДЕН (NO)
Йон Эрик БРЕНДЕН
Аслак ГОДАЛЬ (NO)
Аслак ГОДАЛЬ
Original Assignee
Фотокьюр Аса
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фотокьюр Аса filed Critical Фотокьюр Аса
Publication of RU2003105460A publication Critical patent/RU2003105460A/ru
Application granted granted Critical
Publication of RU2246483C2 publication Critical patent/RU2246483C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2003105460/04A 2000-07-27 2001-07-25 Эфиры 5-аминолевулиновой кислоты как фоточувствительные агенты в фотохимиотерапии RU2246483C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0018528.0 2000-07-27
GBGB0018528.0A GB0018528D0 (en) 2000-07-27 2000-07-27 Compounds

Publications (2)

Publication Number Publication Date
RU2003105460A RU2003105460A (ru) 2004-08-20
RU2246483C2 true RU2246483C2 (ru) 2005-02-20

Family

ID=9896500

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003105460/04A RU2246483C2 (ru) 2000-07-27 2001-07-25 Эфиры 5-аминолевулиновой кислоты как фоточувствительные агенты в фотохимиотерапии

Country Status (19)

Country Link
US (2) US7217736B2 (enExample)
EP (1) EP1313695B1 (enExample)
JP (1) JP5010088B2 (enExample)
KR (1) KR20030028554A (enExample)
CN (1) CN1318388C (enExample)
AT (1) ATE349417T1 (enExample)
AU (2) AU2002227495B2 (enExample)
CA (1) CA2416307C (enExample)
CZ (1) CZ2003260A3 (enExample)
DE (1) DE60125555T2 (enExample)
DK (1) DK1313695T3 (enExample)
ES (1) ES2276844T3 (enExample)
GB (1) GB0018528D0 (enExample)
HU (1) HUP0301427A2 (enExample)
NO (1) NO20030398L (enExample)
NZ (1) NZ523927A (enExample)
PT (1) PT1313695E (enExample)
RU (1) RU2246483C2 (enExample)
WO (1) WO2002010120A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2484111C2 (ru) * 2007-07-31 2013-06-10 Джи-И Хелткер Лимитед Агенты для оптической визуализации
RU2521228C2 (ru) * 2007-12-12 2014-06-27 ФотоКьюэр АСА Применение 5-аминолевулиновой кислоты и ее производных в твердой форме для фотодинамического лечения и диагностики
US10017459B2 (en) 2015-08-03 2018-07-10 Quadriga Biosciences, Inc. β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof
US10034847B2 (en) 2014-02-03 2018-07-31 Quadriga Biosciences, Inc. Beta-substituted beta-amino acids and analogs as chemotherapeutic agents

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492420B2 (en) * 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
CA2653839A1 (en) * 1998-11-02 2000-05-11 John G. Devane Multiparticulate modified release composition
US20090297602A1 (en) * 1998-11-02 2009-12-03 Devane John G Modified Release Loxoprofen Compositions
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
PT1404324E (pt) 2001-06-11 2008-03-05 Xenoport Inc Formas de dosagem administradas oralmente de pró-fármacos análogas de gaba tendo toxicidade reduzida
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
GB0118251D0 (en) * 2001-07-26 2001-09-19 Photocure Asa Method
EP1556091A1 (en) * 2002-10-04 2005-07-27 Elan Pharma International Limited Gamma irradiation of solid nanoparticulate active agents
DE10312659A1 (de) * 2003-03-21 2004-10-07 Universität Regensburg 5-Aminolävulinsäurederivate und ihre Verwendung
WO2004105809A1 (en) * 2003-05-22 2004-12-09 Elan Pharma International Ltd. Sterilization of dispersions of nanoparticulate active agents with gamma radiation
CA2437638A1 (en) 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
GB0406917D0 (en) * 2004-03-26 2004-04-28 Photocure Asa Compounds
JP2005350418A (ja) * 2004-06-11 2005-12-22 Shibuya Kogyo Co Ltd 標的細胞の死滅方法と標的細胞を死滅させるための薬剤及び該薬剤の製造装置
AU2005278649B8 (en) 2004-09-02 2010-07-22 Cosmo Ala Co., Ltd. Constitutional function-improving agents
US8795725B2 (en) 2004-11-04 2014-08-05 Xenoport, Inc. GABA analog prodrug sustained release oral dosage forms
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
JP2008531721A (ja) * 2005-03-03 2008-08-14 エラン・ファルマ・インターナショナル・リミテッド 複素環式アミド誘導体のナノ粒子状組成物
JP4934292B2 (ja) * 2005-07-05 2012-05-16 コスモ石油株式会社 ５−アミノレブリン酸エステルリン酸類塩、その製造方法及びその用途
JP4934293B2 (ja) * 2005-07-05 2012-05-16 コスモ石油株式会社 植物活力剤組成物
GB0609809D0 (en) * 2006-05-17 2006-06-28 Photocure Asa Product
BRPI0714173A2 (pt) * 2006-07-12 2012-12-25 Elan Pharma Int Ltd composiÇço nanoparticulada estÁvel,mÉtodos para preparar a composiÇço, para prevenir e/ou tratar estados de doenÇas, sintomas, sÍndromes e condiÇÕes do sistema nervoso central, para melhorar ou manter a biodisponibilidade de modafinil, e para tratar distérbio com base neurolàgica, composiÇço farmacÊutica, e forma de dosagem
JP5404995B2 (ja) 2006-08-10 2014-02-05 コスモ石油株式会社 植物のポリフェノール増量剤
GB0700580D0 (en) 2007-01-11 2007-02-21 Photocure Asa Use
US20090036952A1 (en) 2007-07-30 2009-02-05 National Yang-Ming University Induction driven light module and use thereof
KR100883560B1 (ko) * 2007-08-23 2009-02-17 (주) 위디어 신규한 5-아미노레불린 산 유도체 및 이의 제조방법
EP2231105A1 (en) * 2007-12-14 2010-09-29 Photoderma SA Novel compounds useful in therapeutic and cosmetic methods
GB0804190D0 (en) * 2008-03-06 2008-04-16 Ge Healthcare Ltd Ester imaging agents
US8563605B2 (en) 2008-05-14 2013-10-22 Sbi Pharmaceuticals Co., Ltd. Therapeutic agent for male sterility
WO2010024775A1 (en) * 2008-09-01 2010-03-04 Swedish Pharma Ab New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
PE20120858A1 (es) * 2009-06-11 2012-08-01 Photocure Asa Composiciones solidas que comprenden acido 5-aminolevulinico
CN102458388B (zh) * 2009-06-11 2016-09-28 光治疗Asa公司 半固体组合物及药物制品
EP2542208A1 (en) 2010-03-01 2013-01-09 Photocure ASA Cosmetic compositions
EP2394642A1 (en) 2010-06-10 2011-12-14 Universite De Geneve 5-ALA ester formulations and use thereof
US20130211215A1 (en) 2010-06-23 2013-08-15 Photocure Asa Hyperosmotic preparations comprising 5-aminolevulinic acid or derivative as photosensitizing agent
KR101842732B1 (ko) 2010-07-09 2018-05-14 포토큐어 에이에스에이 광역동 치료 또는 광역동 진단에 사용하기 위한 건조 조성물 및 이와 같은 건조 조성물을 포함하는 기구
EP2657346B1 (en) 2010-12-24 2017-08-23 ARKRAY, Inc. Method for detecting cancer cell
WO2012097264A2 (en) 2011-01-13 2012-07-19 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
US20140316534A1 (en) 2011-10-14 2014-10-23 Photocure Asa Stent
US20140276107A1 (en) 2011-10-14 2014-09-18 Photocure Asa Photodynamic diagnosis
KR102057349B1 (ko) 2011-12-19 2019-12-18 포토큐어 에이에스에이 광 조사 기구
WO2013092936A2 (en) 2011-12-20 2013-06-27 Galderma Research & Development Use of 5-aminolevulinic acid and esters, in combination with a vitamin d derivative or analog in photochemotherapy, and their uses in treating acne
CA2878846A1 (en) 2012-07-11 2014-01-16 Delphine Caroline Imbert Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
US9249086B2 (en) 2012-08-03 2016-02-02 Photocure Asa Carboxylic acid ALA esters
GB201215675D0 (en) * 2012-09-03 2012-10-17 Univ Exeter Compound
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
EP3082787B1 (en) 2013-12-20 2020-11-25 Galderma Research & Development Pulse photodynamic treatment of photodamaged skin
EP3095464A1 (en) 2015-05-19 2016-11-23 Universite De Geneve 5-ala derivatives and use thereof
GB201522309D0 (en) * 2015-12-17 2016-02-03 Photocure Asa Use
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
CN106187793A (zh) 2016-01-26 2016-12-07 赵鸣 5‑氨基酮戊酸及其衍生物的盐化合物和应用
ES2859777T3 (es) 2017-02-06 2021-10-04 3Skin As Composición de filtro solar
PL3641882T3 (pl) * 2017-06-21 2024-02-26 Photocure Asa Sposób przygotowania ciekłej kompozycji farmaceutycznej oraz urządzenie do stosowania w takim sposobie
EP3868372A1 (en) 2020-02-19 2021-08-25 JLP Health GmbH A pharmaceutical combination of an artemisinin compound and a heme synthesis modulator for treating cancer
CN111635464B (zh) * 2020-05-12 2022-03-25 上海易全化学有限公司 一种5-氨基酮戊酸葡聚糖酯的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996028412A1 (en) * 1995-03-10 1996-09-19 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
RU97116716A (ru) * 1995-03-10 1999-07-10 Фотокьюр АС Сложные эфиры 5-аминолевулиновой кислоты в качестве фотосенсибилизаторов в фотохимиотерапии

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2411382C3 (de) 1974-03-09 1979-09-06 C.H. Boehringer Sohn, 6507 Ingelheim 2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
US4087532A (en) 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
GB2058077B (en) 1979-06-08 1983-03-09 Szelke M Enkephalin analogues
CA1236029A (en) 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide
SE460947B (sv) 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
JPS6452778A (en) * 1987-05-30 1989-02-28 Tokuyama Soda Kk Fulgide compound and production thereof
JPH0745502B2 (ja) * 1987-11-10 1995-05-17 株式会社トクヤマ 新規化合物及びそれを含む組成物
US5422093A (en) 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5234940A (en) 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5079262A (en) 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
US5955490A (en) 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
JP2767318B2 (ja) 1990-04-11 1998-06-18 株式会社コスモ総合研究所 ５―アミノレブリン酸アルキルエステル又はその塩及びその製造方法並びにこれを有効成分とする除草剤
AU655942B2 (en) 1990-10-05 1995-01-19 Queen's University At Kingston Porphyrin derivatives
US5219878A (en) 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
JP2747644B2 (ja) 1993-08-19 1998-05-06 株式会社コスモ総合研究所 植物成長調節剤
GB9318841D0 (en) 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
JP2896963B2 (ja) * 1994-11-28 1999-05-31 株式会社コスモ総合研究所 植物の耐塩性向上剤
US6492420B2 (en) 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6992107B1 (en) * 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
GB9504948D0 (en) * 1995-03-10 1995-04-26 Norwegian Radium Hospital Rese Compounds
US7530461B2 (en) 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
FR2777782B1 (fr) 1998-04-22 2001-05-18 Alexandre Marti Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
GB0118251D0 (en) 2001-07-26 2001-09-19 Photocure Asa Method
GB0128052D0 (en) 2001-11-22 2002-01-16 Drug Discovery Lab As Compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996028412A1 (en) * 1995-03-10 1996-09-19 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
RU97116716A (ru) * 1995-03-10 1999-07-10 Фотокьюр АС Сложные эфиры 5-аминолевулиновой кислоты в качестве фотосенсибилизаторов в фотохимиотерапии

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2484111C2 (ru) * 2007-07-31 2013-06-10 Джи-И Хелткер Лимитед Агенты для оптической визуализации
RU2484111C9 (ru) * 2007-07-31 2013-09-20 Джи-И Хелткер Лимитед Агенты для оптической визуализации
RU2521228C2 (ru) * 2007-12-12 2014-06-27 ФотоКьюэр АСА Применение 5-аминолевулиновой кислоты и ее производных в твердой форме для фотодинамического лечения и диагностики
US10034847B2 (en) 2014-02-03 2018-07-31 Quadriga Biosciences, Inc. Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
US10245246B2 (en) 2014-02-03 2019-04-02 Quadriga Biosciences, Inc. β-substituted β-amino acids and analogs as chemotherapeutic agents
US10017459B2 (en) 2015-08-03 2018-07-10 Quadriga Biosciences, Inc. β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof
US10246406B2 (en) 2015-08-03 2019-04-02 Quadriga Biosciences, Inc. Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof

Also Published As

Publication number Publication date
US20040106679A1 (en) 2004-06-03
DE60125555D1 (de) 2007-02-08
ATE349417T1 (de) 2007-01-15
AU2749502A (en) 2002-02-13
EP1313695A1 (en) 2003-05-28
HUP0301427A2 (hu) 2003-09-29
GB0018528D0 (en) 2000-09-13
CN1460099A (zh) 2003-12-03
JP5010088B2 (ja) 2012-08-29
DE60125555T2 (de) 2007-10-11
JP2004505105A (ja) 2004-02-19
AU2002227495B2 (en) 2006-01-05
NZ523927A (en) 2004-07-30
EP1313695B1 (en) 2006-12-27
CA2416307C (en) 2013-01-22
WO2002010120A1 (en) 2002-02-07
DK1313695T3 (da) 2007-04-30
CA2416307A1 (en) 2002-02-07
CN1318388C (zh) 2007-05-30
US7563819B1 (en) 2009-07-21
ES2276844T3 (es) 2007-07-01
CZ2003260A3 (cs) 2003-06-18
NO20030398L (no) 2003-03-12
KR20030028554A (ko) 2003-04-08
US7217736B2 (en) 2007-05-15
NO20030398D0 (no) 2003-01-24
PT1313695E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
RU2246483C2 (ru) Эфиры 5-аминолевулиновой кислоты как фоточувствительные агенты в фотохимиотерапии
JP5164565B2 (ja) ５−アミノレブリン酸又はその誘導体の酸付加塩
US7287646B2 (en) Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
AU2002227495A1 (en) Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
JP3955093B2 (ja) 光化学治療における光増感剤としての５−アミノレブリン酸のエステル
US7247655B2 (en) Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
RU2191010C2 (ru) Сложные эфиры 5-аминолевулиновой кислоты в качестве фотосенсибилизаторов в фотохимиотерапии

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130726